12-Week, Randomized, Double-Blind, Double-Dummy,Placebo-Controlled, Parallel-Group, Multicenter Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Comparison To Tolterodine ER In Patients With Overactive Bladder (OAB)
12-Week, Randomized, Double-Blind, Double-Dummy,Placebo-Controlled, Parallel-Group, Multicenter Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Comparison To Tolterodine ER In Patients With Overactive Bladder (OAB)
To evaluate the efficacy and safety of fesoterodine in comparison to tolterodine and placebo for overactive bladder
Inclusion Criteria:
Exclusion Criteria:
Shrevport, Louisiana 71106, United States
Rancagua, Región del Libertador General Bernardo O’Higgins 2820945, Chile
Bogota, Cundinamarca 0, Colombia
Bogota, Cundinamarca, Colombia
Nykoebing Falster, 4800, Denmark
Muelheim A.d. Ruhr, 45468, Germany
Rio, Patras, 26500, Greece
Hyderabad, Andhra Pradesh 500 001, India
Hyderabad, Andhra Pradesh 500 082, India
Niao-Sung Hsiang, Kaohsiung 833, Taiwan